LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)

Journal of Neuroimmunology

Volumn 215, Issue 1-2, 2009, Pages 36-42

  Maggi, Laura ^a   Trettel, Flavia ^a   Scianni, Maria ^a   Bertollini, Cristina ^a   Eusebi, Fabrizio ^a,b   Fredholm, Bertil B ^c   Limatola, Cristina ^a,b  

^a Pasteur Institute   (Italy)

^b IRCCS NEUROMED   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine receptor; Chemokine; fEPSP; Glutamate receptor; Hippocampus; LTP

Indexed keywords

ADENOSINE A3 RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; OKADAIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CHEMOKINE CX3CL1; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL INHIBITION; RECEPTOR, ADENOSINE A3;

EID: 70349731426     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.07.016     Document Type: Article

References (48)

1. Asensio V.C., and Campbell I.L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22 (1999) 504-512
2. 3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51 (2006) 816-821
3. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNF: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4 (2001) 702-710
4. Bliss T.V., and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232 (1973) 331-356
5. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
6. Boulanger L.M., Huh G.S., and Shatz C.J. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Curr. Opin. Neurobiol. 11 (2001) 568-578
7. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., and Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006) 917-924
8. Chapman G.A., Moores K., Harrison D., Campbell C.A., Steward B.R., and Strijbos P.J.L.M. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20 (2000) RC87
9. Chen J.F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M.A., Fink J.S., and Schwarzschild M.A. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19 (1999) 9192-9200
10. Chun J. Selected comparison of immune and nervous system development. Adv. Immunol. 77 (2001) 297-322
11. Costenla A.R., Lopes L.V., de Mendonça A., and Ribeiro J.A. A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci. Lett. 302 (2001) 53-57
12. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38 (2001) 107-125
13. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., and O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203 (1996) 17-20
14. Curran B., and O'Connor J.J. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108 (2001) 83-90
15. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24 (2001) 31-55
16. Dunwiddie T.V., Diao L., Kim H.O., Jiang J.L., and Jacobson K.A. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17 (1997) 607-614
17. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14 (2007) 1315-1323
18. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., and Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 63 (2005) 191-270
19. Fujii S. ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation. J. Pharmacol. Sci. 94 (2004) 103-106
20. Gillard S.E., Lu M., Mastracci R.M., and Miller R.J. Expression of functional chemokine receptors by rat cerebellar neurons. J. Neuroimmunol. 124 (2002) 16-28
21. Giménez-Llort L., Masino S.A., Diao L., Fernández-Teruel A., Tobeña A., Halldner L., and Fredholm B.B. Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly. Synapse 57 (2005) 8-16
22. Giovannelli A., Limatola C., Ragozzino D., Mileo A.M., Ruggieri A., Ciotti M.T., Mercanti D., Santoni A., and Eusebi F. CXC chemokines interleukin-8 (IL-8) and growth-related gene product (GRO) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92 (1998) 122-132
23. Griffin R., Nally R., Nolan Y., McCartney Y., Linden J., and Lynch M. The age-related attenuation in long-term potentiation is associated with microglial activation. J. Neurochem. 99 (2006) 1263-1272
24. Hammarberg C., Schulte G., and Fredholm B.B. Evidence for functional adenosine A3 receptors in microglia cells. J. Neurochem. 86 (2003) 1051-1054
25. Håkansson K., Galdi S., Hendrick J., Snyder G., Greengard P., and Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J. Neurochem. 96 (2006) 482-488
26. 3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95 (1998) 10896-10901
27. Hatori K., Nagai A., Heisel R., Ryu J.K., and Kim S.U. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69 (2002) 418-426
28. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., and Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 176 (2002) 336-341
29. 3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37 (2002) 314-327
30. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Gimenez-Llort L., Escorihuela R.M., Fernandez-Teruel A., Wiesenfeld-Hallin Z., Xu X.J., Hardemark A., Betsholtz C., Herlenius E., and Fredholm B.B. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA 98 (2001) 9407-9412
31. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., and Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20 (2000) 4106-4114
32. Kessey K., Trommer B.L., Overstreet L.S., Ji T., and Mogul D.J. A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus. Brain Res. 756 (1997) 184-190
33. 3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 80 (2008) 7590-7596
34. Lax P., Limatola C., Fucile S., Trettel F., Di Bartolomeo S., Renzi M., Ragozzino D., and Eusebi F. Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cells. J. Neuroimmunol. 129 (2002) 66-73
35. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., and Eusebi F. SDF-1-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 12 (2000) 2497-2504
36. 3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 166 (2005) 19-28
37. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., and Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95 (1998) 14500-14505
38. 3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97 (2000) 8075-8080
39. Oh S.B., Endoh T., Simen A.A., Ren D., and Miller R.J. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 123 (2002) 66-75
40. Ragozzino D., Renzi M., Giovannelli A., and Eusebi F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 127 (2002) 30-36
41. 3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 26 (2006) 10488-10498
42. Salvatore C.A., Tilley S.L., Latour A.M., Fletcher D.S., Koller B.H., and Jacobson M.A. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275 (2000) 4429-4434
43. Tran P.B., and Miller R.J. Chemokine receptors: signposts to brain development and disease. Nat. Rev., Neurosci. 4 (2003) 444-455
44. Tsien J.Z., Huerta P.T., and Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87 (1996) 1327-1338
45. Winder D.G., and Sweatt J.D. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat. Rev., Neurosci. 2 (2001) 461-474
46. Woo N.H., Abel T., and Nguyen P.V. Genetic and pharmacological demonstration of a role for cyclic AMP-dependent protein kinase-mediated suppression of protein phosphatases in gating the expression of late LTP. Eur. J. Neurosci. 16 (2002) 1871-1876
47. Woo N.H., Duffy S.N., Abel T., and Nguyen P.V. Temporal spacing of synaptic stimulation critically modulates the dependence of LTP on cyclic AMP-dependent protein kinase. Hippocampus 13 (2003) 293-300
48. Zujovic V., Benavides J., Vigé X., Carter C., and Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29 (2000) 305-315